metastatic/unresectable CEA+ solid tumorsNCT02004106Cergutuzumab amunaleukinCA
…hase I, dose-escalation study investigating CA in patients with metastatic/unresectable CEA+ solid tumors ( NCT02004106).Methods Patients received ascending doses of CA …